NZ553273A

NZ553273A - Treating gliosis, glial scarring, inflammation or inhibition of a xonal growth in the nervous system with an antagonist of EphA4-mediated signalling

Treating gliosis, glial scarring, inflammation or inhibition of a xonal growth in the nervous system with an antagonist of EphA4-mediated signalling

Info

Publication number: NZ553273A
Authority: NZ; New Zealand
Prior art keywords: epha4; nervous system; antagonist; gliosis; molecule
Prior art date: 2004-09-08

Application number

NZ553273A

Other languages

English (en)

Inventor

Perry F Bartlett

Mary P Galea

Ann M Turnley

Yona Goldshmit

Andrew W Boyd

Original Assignee

Univ Melbourne

Univ Queensland

Priority date

2004-09-08

Filing date

2005-09-08

Publication date

2009-11-27

2004-09-08 Priority claimed from AU2004905148A external-priority patent/AU2004905148A0/en

2005-09-08 Application filed by Univ Melbourne, Univ Queensland filed Critical Univ Melbourne

2009-11-27 Publication of NZ553273A publication Critical patent/NZ553273A/en

Links

108010055179 EphA4 Receptor Proteins 0.000 title claims abstract description 104
102000021727 EphA4 Receptor Human genes 0.000 title claims abstract description 104
206010018341 Gliosis Diseases 0.000 title claims abstract description 50
230000001404 mediated effect Effects 0.000 title claims abstract description 40
230000007387 gliosis Effects 0.000 title claims abstract description 35
230000011664 signaling Effects 0.000 title claims abstract description 31
239000005557 antagonist Substances 0.000 title claims abstract description 30
230000002518 glial effect Effects 0.000 title claims abstract description 28
230000037390 scarring Effects 0.000 title claims abstract description 26
210000000653 nervous system Anatomy 0.000 title claims abstract description 20
206010061218 Inflammation Diseases 0.000 title description 25
230000004054 inflammatory process Effects 0.000 title description 25
230000005764 inhibitory process Effects 0.000 title description 19
230000012010 growth Effects 0.000 title description 14
239000003814 drug Substances 0.000 claims abstract description 19
238000004519 manufacturing process Methods 0.000 claims abstract description 5
210000000278 spinal cord Anatomy 0.000 claims description 37
150000007523 nucleic acids Chemical group 0.000 claims description 36
102000039446 nucleic acids Human genes 0.000 claims description 34
108020004707 nucleic acids Proteins 0.000 claims description 34
230000006378 damage Effects 0.000 claims description 32
208000014674 injury Diseases 0.000 claims description 31
208000027418 Wounds and injury Diseases 0.000 claims description 27
239000003446 ligand Substances 0.000 claims description 25
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
102000012803 ephrin Human genes 0.000 claims description 22
108060002566 ephrin Proteins 0.000 claims description 22
230000007423 decrease Effects 0.000 claims description 20
230000000692 anti-sense effect Effects 0.000 claims description 19
230000027455 binding Effects 0.000 claims description 18
201000010099 disease Diseases 0.000 claims description 18
210000003169 central nervous system Anatomy 0.000 claims description 17
108020004999 messenger RNA Proteins 0.000 claims description 17
210000004556 brain Anatomy 0.000 claims description 11
108091030071 RNAI Proteins 0.000 claims description 7
230000009368 gene silencing by RNA Effects 0.000 claims description 7
206010033799 Paralysis Diseases 0.000 claims description 4
239000000427 antigen Substances 0.000 claims description 3
102000036639 antigens Human genes 0.000 claims description 3
108091007433 antigens Proteins 0.000 claims description 3
230000008733 trauma Effects 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 description 74
238000000034 method Methods 0.000 description 62
230000003902 lesion Effects 0.000 description 58
108090000765 processed proteins & peptides Proteins 0.000 description 58
210000004027 cell Anatomy 0.000 description 55
241000699670 Mus sp. Species 0.000 description 53
210000001130 astrocyte Anatomy 0.000 description 53
150000001875 compounds Chemical class 0.000 description 43
108091008815 Eph receptors Proteins 0.000 description 40
102000050554 Eph Family Receptors Human genes 0.000 description 39
210000003050 axon Anatomy 0.000 description 36
102000004196 processed proteins & peptides Human genes 0.000 description 34
108090000623 proteins and genes Proteins 0.000 description 32
230000003376 axonal effect Effects 0.000 description 29
210000002569 neuron Anatomy 0.000 description 28
230000006870 function Effects 0.000 description 26
230000014509 gene expression Effects 0.000 description 26
239000000203 mixture Substances 0.000 description 26
230000008929 regeneration Effects 0.000 description 26
238000011069 regeneration method Methods 0.000 description 26
238000002347 injection Methods 0.000 description 25
239000007924 injection Substances 0.000 description 25
239000002773 nucleotide Substances 0.000 description 24
125000003729 nucleotide group Chemical group 0.000 description 23
108091034117 Oligonucleotide Proteins 0.000 description 22
235000001014 amino acid Nutrition 0.000 description 21
229940024606 amino acid Drugs 0.000 description 21
229920001184 polypeptide Polymers 0.000 description 21
108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
150000001413 amino acids Chemical class 0.000 description 18
241001465754 Metazoa Species 0.000 description 16
230000004913 activation Effects 0.000 description 16
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 15
235000018102 proteins Nutrition 0.000 description 15
102000004169 proteins and genes Human genes 0.000 description 15
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 14
230000004048 modification Effects 0.000 description 14
238000012986 modification Methods 0.000 description 14
239000008194 pharmaceutical composition Substances 0.000 description 14
230000000694 effects Effects 0.000 description 13
238000009472 formulation Methods 0.000 description 13
230000014511 neuron projection development Effects 0.000 description 13
108020004414 DNA Proteins 0.000 description 12
-1 EphBl Proteins 0.000 description 12
101710193519 Glial fibrillary acidic protein Proteins 0.000 description 12
206010061431 Glial scar Diseases 0.000 description 12
210000005046 glial fibrillary acidic protein Anatomy 0.000 description 12
102000004127 Cytokines Human genes 0.000 description 11
108090000695 Cytokines Proteins 0.000 description 11
102100039289 Glial fibrillary acidic protein Human genes 0.000 description 11
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
102000004058 Leukemia inhibitory factor Human genes 0.000 description 11
108090000581 Leukemia inhibitory factor Proteins 0.000 description 11
238000009396 hybridization Methods 0.000 description 11
102000040430 polynucleotide Human genes 0.000 description 11
108091033319 polynucleotide Proteins 0.000 description 11
239000002157 polynucleotide Substances 0.000 description 11
208000020431 spinal cord injury Diseases 0.000 description 11
239000000126 substance Substances 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 10
238000011161 development Methods 0.000 description 10
230000018109 developmental process Effects 0.000 description 10
239000012634 fragment Substances 0.000 description 10
230000001537 neural effect Effects 0.000 description 10
210000002241 neurite Anatomy 0.000 description 10
150000003839 salts Chemical class 0.000 description 10
239000000243 solution Substances 0.000 description 10
229940124597 therapeutic agent Drugs 0.000 description 10
101800001318 Capsid protein VP4 Proteins 0.000 description 9
102100027609 Rho-related GTP-binding protein RhoD Human genes 0.000 description 9
230000003247 decreasing effect Effects 0.000 description 9
230000004044 response Effects 0.000 description 9
230000014616 translation Effects 0.000 description 9
238000007792 addition Methods 0.000 description 8
239000003937 drug carrier Substances 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
238000013459 approach Methods 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000002068 genetic effect Effects 0.000 description 7
230000001969 hypertrophic effect Effects 0.000 description 7
239000002502 liposome Substances 0.000 description 7
230000033001 locomotion Effects 0.000 description 7
239000000843 powder Substances 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
238000012360 testing method Methods 0.000 description 7
230000001225 therapeutic effect Effects 0.000 description 7
238000013519 translation Methods 0.000 description 7
238000011282 treatment Methods 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
208000012902 Nervous system disease Diseases 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
230000003140 astrocytic effect Effects 0.000 description 6
239000000835 fiber Substances 0.000 description 6
230000002757 inflammatory effect Effects 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
239000007788 liquid Substances 0.000 description 6
239000002777 nucleoside Substances 0.000 description 6
230000026731 phosphorylation Effects 0.000 description 6
238000006366 phosphorylation reaction Methods 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
230000001172 regenerating effect Effects 0.000 description 6
238000012216 screening Methods 0.000 description 6
239000004471 Glycine Substances 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
238000010521 absorption reaction Methods 0.000 description 5
125000003275 alpha amino acid group Chemical group 0.000 description 5
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
230000028600 axonogenesis Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
238000012217 deletion Methods 0.000 description 5
230000037430 deletion Effects 0.000 description 5
239000006185 dispersion Substances 0.000 description 5
210000002683 foot Anatomy 0.000 description 5
238000012744 immunostaining Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
230000003993 interaction Effects 0.000 description 5
230000003447 ipsilateral effect Effects 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
239000002609 medium Substances 0.000 description 5
210000004498 neuroglial cell Anatomy 0.000 description 5
230000008569 process Effects 0.000 description 5
230000009467 reduction Effects 0.000 description 5
238000006722 reduction reaction Methods 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 4
108700020796 Oncogene Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
238000000692 Student's t-test Methods 0.000 description 4
108020005038 Terminator Codon Proteins 0.000 description 4
239000002253 acid Substances 0.000 description 4
230000009471 action Effects 0.000 description 4
239000013543 active substance Substances 0.000 description 4
125000003277 amino group Chemical group 0.000 description 4
239000002775 capsule Substances 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
210000003618 cortical neuron Anatomy 0.000 description 4
230000029087 digestion Effects 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
230000004927 fusion Effects 0.000 description 4
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
239000011521 glass Substances 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
239000012528 membrane Substances 0.000 description 4
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
125000004437 phosphorous atom Chemical group 0.000 description 4
229910052698 phosphorus Inorganic materials 0.000 description 4
239000003755 preservative agent Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
238000011084 recovery Methods 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
230000036573 scar formation Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
241000894007 species Species 0.000 description 4
230000001629 suppression Effects 0.000 description 4
239000003826 tablet Substances 0.000 description 4
230000008685 targeting Effects 0.000 description 4
210000003371 toe Anatomy 0.000 description 4
230000014621 translational initiation Effects 0.000 description 4
230000003827 upregulation Effects 0.000 description 4
238000005406 washing Methods 0.000 description 4
238000001262 western blot Methods 0.000 description 4
102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 3
LHYQAEFVHIZFLR-UHFFFAOYSA-L 4-(4-diazonio-3-methoxyphenyl)-2-methoxybenzenediazonium;dichloride Chemical compound [Cl-].[Cl-].C1=C([N+]#N)C(OC)=CC(C=2C=C(OC)C([N+]#N)=CC=2)=C1 LHYQAEFVHIZFLR-UHFFFAOYSA-L 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
239000004971 Cross linker Substances 0.000 description 3
229920002307 Dextran Polymers 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
108020004459 Small interfering RNA Proteins 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
108091081024 Start codon Proteins 0.000 description 3
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
239000000443 aerosol Substances 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
208000037875 astrocytosis Diseases 0.000 description 3
230000007341 astrogliosis Effects 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
239000000969 carrier Substances 0.000 description 3
210000005056 cell body Anatomy 0.000 description 3
238000001516 cell proliferation assay Methods 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
238000012875 competitive assay Methods 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
238000013461 design Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000007877 drug screening Methods 0.000 description 3
230000030279 gene silencing Effects 0.000 description 3
125000000623 heterocyclic group Chemical group 0.000 description 3
210000000548 hind-foot Anatomy 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000001114 immunoprecipitation Methods 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
238000002372 labelling Methods 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
210000003141 lower extremity Anatomy 0.000 description 3
239000000463 material Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
150000003833 nucleoside derivatives Chemical class 0.000 description 3
125000003835 nucleoside group Chemical group 0.000 description 3
230000037361 pathway Effects 0.000 description 3
210000002804 pyramidal tract Anatomy 0.000 description 3
210000000463 red nucleus Anatomy 0.000 description 3
239000002904 solvent Substances 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
239000000725 suspension Substances 0.000 description 3
230000002459 sustained effect Effects 0.000 description 3
238000011144 upstream manufacturing Methods 0.000 description 3
239000013598 vector Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
AXDLCFOOGCNDST-VIFPVBQESA-N (2s)-3-(4-hydroxyphenyl)-2-(methylamino)propanoic acid Chemical compound CN[C@H](C(O)=O)CC1=CC=C(O)C=C1 AXDLCFOOGCNDST-VIFPVBQESA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
QGZCUOLOTMJILH-UHFFFAOYSA-N 2h-tetrazol-2-ium;bromide Chemical compound [Br-].C1=N[NH+]=NN1 QGZCUOLOTMJILH-UHFFFAOYSA-N 0.000 description 2
GAUBNQMYYJLWNF-UHFFFAOYSA-N 3-(Carboxymethylamino)propanoic acid Chemical compound OC(=O)CCNCC(O)=O GAUBNQMYYJLWNF-UHFFFAOYSA-N 0.000 description 2
DFVFTMTWCUHJBL-UHFFFAOYSA-N 4-azaniumyl-3-hydroxy-6-methylheptanoate Chemical compound CC(C)CC(N)C(O)CC(O)=O DFVFTMTWCUHJBL-UHFFFAOYSA-N 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
206010051290 Central nervous system lesion Diseases 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
244000205754 Colocasia esculenta Species 0.000 description 2
235000006481 Colocasia esculenta Nutrition 0.000 description 2
QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 2
229940122293 Ephrin antagonist Drugs 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
102100021831 Myelin-associated glycoprotein Human genes 0.000 description 2
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
208000001738 Nervous System Trauma Diseases 0.000 description 2
206010029240 Neuritis Diseases 0.000 description 2
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108010077895 Sarcosine Proteins 0.000 description 2
108020003224 Small Nucleolar RNA Proteins 0.000 description 2
102000042773 Small Nucleolar RNA Human genes 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
230000010933 acylation Effects 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
239000000556 agonist Substances 0.000 description 2
230000029936 alkylation Effects 0.000 description 2
238000005804 alkylation reaction Methods 0.000 description 2
239000000074 antisense oligonucleotide Substances 0.000 description 2
238000012230 antisense oligonucleotides Methods 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000021235 carbamoylation Effects 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
150000007942 carboxylates Chemical class 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
125000003636 chemical group Chemical group 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000009194 climbing Effects 0.000 description 2
238000002648 combination therapy Methods 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000006071 cream Substances 0.000 description 2
XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 2
XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
230000003436 cytoskeletal effect Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
230000003292 diminished effect Effects 0.000 description 2
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
230000007783 downstream signaling Effects 0.000 description 2
238000009510 drug design Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000007710 freezing Methods 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000012226 gene silencing method Methods 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
210000000020 growth cone Anatomy 0.000 description 2
206010073071 hepatocellular carcinoma Diseases 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
230000002055 immunohistochemical effect Effects 0.000 description 2
JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 2
238000002684 laminectomy Methods 0.000 description 2
238000013507 mapping Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
229960001913 mecysteine Drugs 0.000 description 2
230000011987 methylation Effects 0.000 description 2
238000007069 methylation reaction Methods 0.000 description 2
108091070501 miRNA Proteins 0.000 description 2
210000000274 microglia Anatomy 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
230000004001 molecular interaction Effects 0.000 description 2
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
230000004766 neurogenesis Effects 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
239000002674 ointment Substances 0.000 description 2
210000004248 oligodendroglia Anatomy 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
238000002823 phage display Methods 0.000 description 2
OJUGVDODNPJEEC-UHFFFAOYSA-N phenylglyoxal Chemical compound O=CC(=O)C1=CC=CC=C1 OJUGVDODNPJEEC-UHFFFAOYSA-N 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
230000032361 posttranscriptional gene silencing Effects 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
239000002243 precursor Substances 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
239000003380 propellant Substances 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
108091008598 receptor tyrosine kinases Proteins 0.000 description 2
102000027426 receptor tyrosine kinases Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
230000010076 replication Effects 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
239000000523 sample Substances 0.000 description 2
231100000241 scar Toxicity 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000002356 single layer Substances 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000000375 suspending agent Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000005945 translocation Effects 0.000 description 2
230000001720 vestibular Effects 0.000 description 2
CWLQUGTUXBXTLF-RXMQYKEDSA-N (2r)-1-methylpyrrolidine-2-carboxylic acid Chemical compound CN1CCC[C@@H]1C(O)=O CWLQUGTUXBXTLF-RXMQYKEDSA-N 0.000 description 1
YAXAFCHJCYILRU-RXMQYKEDSA-N (2r)-2-(methylamino)-4-methylsulfanylbutanoic acid Chemical compound CN[C@@H](C(O)=O)CCSC YAXAFCHJCYILRU-RXMQYKEDSA-N 0.000 description 1
XLBVNMSMFQMKEY-SCSAIBSYSA-N (2r)-2-(methylamino)pentanedioic acid Chemical compound CN[C@@H](C(O)=O)CCC(O)=O XLBVNMSMFQMKEY-SCSAIBSYSA-N 0.000 description 1
GDFAOVXKHJXLEI-GSVOUGTGSA-N (2r)-2-(methylamino)propanoic acid Chemical compound CN[C@H](C)C(O)=O GDFAOVXKHJXLEI-GSVOUGTGSA-N 0.000 description 1
SCIFESDRCALIIM-SECBINFHSA-N (2r)-2-(methylazaniumyl)-3-phenylpropanoate Chemical compound CN[C@@H](C(O)=O)CC1=CC=CC=C1 SCIFESDRCALIIM-SECBINFHSA-N 0.000 description 1
CYZKJBZEIFWZSR-ZCFIWIBFSA-N (2r)-3-(1h-imidazol-5-yl)-2-(methylamino)propanoic acid Chemical compound CN[C@@H](C(O)=O)CC1=CN=CN1 CYZKJBZEIFWZSR-ZCFIWIBFSA-N 0.000 description 1
CZCIKBSVHDNIDH-LLVKDONJSA-N (2r)-3-(1h-indol-3-yl)-2-(methylamino)propanoic acid Chemical compound C1=CC=C2C(C[C@@H](NC)C(O)=O)=CNC2=C1 CZCIKBSVHDNIDH-LLVKDONJSA-N 0.000 description 1
AKCRVYNORCOYQT-RXMQYKEDSA-N (2r)-3-methyl-2-(methylazaniumyl)butanoate Chemical compound C[NH2+][C@H](C(C)C)C([O-])=O AKCRVYNORCOYQT-RXMQYKEDSA-N 0.000 description 1
LNSMPSPTFDIWRQ-GSVOUGTGSA-N (2r)-4-amino-2-(methylamino)-4-oxobutanoic acid Chemical compound CN[C@@H](C(O)=O)CC(N)=O LNSMPSPTFDIWRQ-GSVOUGTGSA-N 0.000 description 1
NTWVQPHTOUKMDI-RXMQYKEDSA-N (2r)-5-(diaminomethylideneamino)-2-(methylamino)pentanoic acid Chemical compound CN[C@@H](C(O)=O)CCCNC(N)=N NTWVQPHTOUKMDI-RXMQYKEDSA-N 0.000 description 1
KSZFSNZOGAXEGH-SCSAIBSYSA-N (2r)-5-amino-2-(methylamino)-5-oxopentanoic acid Chemical compound CN[C@@H](C(O)=O)CCC(N)=O KSZFSNZOGAXEGH-SCSAIBSYSA-N 0.000 description 1
OZRWQPFBXDVLAH-RXMQYKEDSA-N (2r)-5-amino-2-(methylamino)pentanoic acid Chemical compound CN[C@@H](C(O)=O)CCCN OZRWQPFBXDVLAH-RXMQYKEDSA-N 0.000 description 1
KSPIYJQBLVDRRI-NTSWFWBYSA-N (2r,3s)-3-methyl-2-(methylazaniumyl)pentanoate Chemical compound CC[C@H](C)[C@@H](NC)C(O)=O KSPIYJQBLVDRRI-NTSWFWBYSA-N 0.000 description 1
BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
LDUWTIUXPVCEQF-LURJTMIESA-N (2s)-2-(cyclopentylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1CCCC1 LDUWTIUXPVCEQF-LURJTMIESA-N 0.000 description 1
NVXKJPGRZSDYPK-JTQLQIEISA-N (2s)-2-(methylamino)-4-phenylbutanoic acid Chemical compound CN[C@H](C(O)=O)CCC1=CC=CC=C1 NVXKJPGRZSDYPK-JTQLQIEISA-N 0.000 description 1
HOKKHZGPKSLGJE-VKHMYHEASA-N (2s)-2-(methylamino)butanedioic acid Chemical compound CN[C@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-VKHMYHEASA-N 0.000 description 1
FPDYKABXINADKS-LURJTMIESA-N (2s)-2-(methylazaniumyl)hexanoate Chemical compound CCCC[C@H](NC)C(O)=O FPDYKABXINADKS-LURJTMIESA-N 0.000 description 1
HCPKYUNZBPVCHC-YFKPBYRVSA-N (2s)-2-(methylazaniumyl)pentanoate Chemical compound CCC[C@H](NC)C(O)=O HCPKYUNZBPVCHC-YFKPBYRVSA-N 0.000 description 1
WTDHSXGBDZBWAW-QMMMGPOBSA-N (2s)-2-[cyclohexyl(methyl)azaniumyl]propanoate Chemical compound OC(=O)[C@H](C)N(C)C1CCCCC1 WTDHSXGBDZBWAW-QMMMGPOBSA-N 0.000 description 1
IUYZJPXOXGRNNE-ZETCQYMHSA-N (2s)-2-[cyclopentyl(methyl)amino]propanoic acid Chemical compound OC(=O)[C@H](C)N(C)C1CCCC1 IUYZJPXOXGRNNE-ZETCQYMHSA-N 0.000 description 1
NPDBDJFLKKQMCM-SCSAIBSYSA-N (2s)-2-amino-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)[C@H](N)C(O)=O NPDBDJFLKKQMCM-SCSAIBSYSA-N 0.000 description 1
KWWFNGCKGYUCLC-RXMQYKEDSA-N (2s)-3,3-dimethyl-2-(methylamino)butanoic acid Chemical compound CN[C@H](C(O)=O)C(C)(C)C KWWFNGCKGYUCLC-RXMQYKEDSA-N 0.000 description 1
XKZCXMNMUMGDJG-AWEZNQCLSA-N (2s)-3-[(6-acetylnaphthalen-2-yl)amino]-2-aminopropanoic acid Chemical compound C1=C(NC[C@H](N)C(O)=O)C=CC2=CC(C(=O)C)=CC=C21 XKZCXMNMUMGDJG-AWEZNQCLSA-N 0.000 description 1
LNSMPSPTFDIWRQ-VKHMYHEASA-N (2s)-4-amino-2-(methylamino)-4-oxobutanoic acid Chemical compound CN[C@H](C(O)=O)CC(N)=O LNSMPSPTFDIWRQ-VKHMYHEASA-N 0.000 description 1
XJODGRWDFZVTKW-LURJTMIESA-N (2s)-4-methyl-2-(methylamino)pentanoic acid Chemical compound CN[C@H](C(O)=O)CC(C)C XJODGRWDFZVTKW-LURJTMIESA-N 0.000 description 1
KSZFSNZOGAXEGH-BYPYZUCNSA-N (2s)-5-amino-2-(methylamino)-5-oxopentanoic acid Chemical compound CN[C@H](C(O)=O)CCC(N)=O KSZFSNZOGAXEGH-BYPYZUCNSA-N 0.000 description 1
OZRWQPFBXDVLAH-YFKPBYRVSA-N (2s)-5-amino-2-(methylamino)pentanoic acid Chemical compound CN[C@H](C(O)=O)CCCN OZRWQPFBXDVLAH-YFKPBYRVSA-N 0.000 description 1
RHMALYOXPBRJBG-WXHCCQJTSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[2-[[(2s,3r)-2-[[(2s)-2-[[2-[[2-[[(2r)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoyl]amino]- Chemical compound C([C@@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)CNC(=O)CNC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RHMALYOXPBRJBG-WXHCCQJTSA-N 0.000 description 1
LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
KMOUUZVZFBCRAM-OLQVQODUSA-N (3as,7ar)-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C=CC[C@@H]2C(=O)OC(=O)[C@@H]21 KMOUUZVZFBCRAM-OLQVQODUSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
WAAJQPAIOASFSC-UHFFFAOYSA-N 2-(1-hydroxyethylamino)acetic acid Chemical compound CC(O)NCC(O)=O WAAJQPAIOASFSC-UHFFFAOYSA-N 0.000 description 1
UEQSFWNXRZJTKB-UHFFFAOYSA-N 2-(2,2-diphenylethylamino)acetic acid Chemical compound C=1C=CC=CC=1C(CNCC(=O)O)C1=CC=CC=C1 UEQSFWNXRZJTKB-UHFFFAOYSA-N 0.000 description 1
PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical compound NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
XCDGCRLSSSSBIA-UHFFFAOYSA-N 2-(2-methylsulfanylethylamino)acetic acid Chemical compound CSCCNCC(O)=O XCDGCRLSSSSBIA-UHFFFAOYSA-N 0.000 description 1
STMXJQHRRCPJCJ-UHFFFAOYSA-N 2-(3,3-diphenylpropylamino)acetic acid Chemical compound C=1C=CC=CC=1C(CCNCC(=O)O)C1=CC=CC=C1 STMXJQHRRCPJCJ-UHFFFAOYSA-N 0.000 description 1
DHGYLUFLENKZHH-UHFFFAOYSA-N 2-(3-aminopropylamino)acetic acid Chemical compound NCCCNCC(O)=O DHGYLUFLENKZHH-UHFFFAOYSA-N 0.000 description 1
OGAULEBSQQMUKP-UHFFFAOYSA-N 2-(4-aminobutylamino)acetic acid Chemical compound NCCCCNCC(O)=O OGAULEBSQQMUKP-UHFFFAOYSA-N 0.000 description 1
KGSVNOLLROCJQM-UHFFFAOYSA-N 2-(benzylamino)acetic acid Chemical compound OC(=O)CNCC1=CC=CC=C1 KGSVNOLLROCJQM-UHFFFAOYSA-N 0.000 description 1
KFDPCYZHENQOBV-UHFFFAOYSA-N 2-(bromomethyl)-4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1CBr KFDPCYZHENQOBV-UHFFFAOYSA-N 0.000 description 1
IVCQRTJVLJXKKJ-UHFFFAOYSA-N 2-(butan-2-ylazaniumyl)acetate Chemical compound CCC(C)NCC(O)=O IVCQRTJVLJXKKJ-UHFFFAOYSA-N 0.000 description 1
FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
KQLGGQARRCMYGD-UHFFFAOYSA-N 2-(cyclobutylamino)acetic acid Chemical compound OC(=O)CNC1CCC1 KQLGGQARRCMYGD-UHFFFAOYSA-N 0.000 description 1
DICMQVOBSKLBBN-UHFFFAOYSA-N 2-(cyclodecylamino)acetic acid Chemical compound OC(=O)CNC1CCCCCCCCC1 DICMQVOBSKLBBN-UHFFFAOYSA-N 0.000 description 1
NPLBBQAAYSJEMO-UHFFFAOYSA-N 2-(cycloheptylazaniumyl)acetate Chemical compound OC(=O)CNC1CCCCCC1 NPLBBQAAYSJEMO-UHFFFAOYSA-N 0.000 description 1
OQMYZVWIXPPDDE-UHFFFAOYSA-N 2-(cyclohexylazaniumyl)acetate Chemical compound OC(=O)CNC1CCCCC1 OQMYZVWIXPPDDE-UHFFFAOYSA-N 0.000 description 1
PNKNDNFLQNMQJL-UHFFFAOYSA-N 2-(cyclooctylazaniumyl)acetate Chemical compound OC(=O)CNC1CCCCCCC1 PNKNDNFLQNMQJL-UHFFFAOYSA-N 0.000 description 1
DXQCCQKRNWMECV-UHFFFAOYSA-N 2-(cyclopropylazaniumyl)acetate Chemical compound OC(=O)CNC1CC1 DXQCCQKRNWMECV-UHFFFAOYSA-N 0.000 description 1
PRVOMNLNSHAUEI-UHFFFAOYSA-N 2-(cycloundecylamino)acetic acid Chemical compound OC(=O)CNC1CCCCCCCCCC1 PRVOMNLNSHAUEI-UHFFFAOYSA-N 0.000 description 1
HEPOIJKOXBKKNJ-UHFFFAOYSA-N 2-(propan-2-ylazaniumyl)acetate Chemical compound CC(C)NCC(O)=O HEPOIJKOXBKKNJ-UHFFFAOYSA-N 0.000 description 1
102100027962 2-5A-dependent ribonuclease Human genes 0.000 description 1
108010000834 2-5A-dependent ribonuclease Proteins 0.000 description 1
AWEZYTUWDZADKR-UHFFFAOYSA-N 2-[(2-amino-2-oxoethyl)azaniumyl]acetate Chemical compound NC(=O)CNCC(O)=O AWEZYTUWDZADKR-UHFFFAOYSA-N 0.000 description 1
MNDBDVPDSHGIHR-UHFFFAOYSA-N 2-[(3-amino-3-oxopropyl)amino]acetic acid Chemical compound NC(=O)CCNCC(O)=O MNDBDVPDSHGIHR-UHFFFAOYSA-N 0.000 description 1
YDBPFLZECVWPSH-UHFFFAOYSA-N 2-[3-(diaminomethylideneamino)propylamino]acetic acid Chemical compound NC(=N)NCCCNCC(O)=O YDBPFLZECVWPSH-UHFFFAOYSA-N 0.000 description 1
108020005345 3' Untranslated Regions Proteins 0.000 description 1
LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
FBTSQILOGYXGMD-LURJTMIESA-N 3-nitro-L-tyrosine Chemical class OC(=O)[C@@H](N)CC1=CC=C(O)C([N+]([O-])=O)=C1 FBTSQILOGYXGMD-LURJTMIESA-N 0.000 description 1
101800000535 3C-like proteinase Proteins 0.000 description 1
101800002396 3C-like proteinase nsp5 Proteins 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
JAJQQUQHMLWDFB-UHFFFAOYSA-N 4-azaniumyl-3-hydroxy-5-phenylpentanoate Chemical compound OC(=O)CC(O)C(N)CC1=CC=CC=C1 JAJQQUQHMLWDFB-UHFFFAOYSA-N 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
208000035657 Abasia Diseases 0.000 description 1
208000012260 Accidental injury Diseases 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
108091023037 Aptamer Proteins 0.000 description 1
101100188555 Arabidopsis thaliana OCT6 gene Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
HDBSOQAIYPWDKZ-UHFFFAOYSA-N C(=O)(O)C1(CC1)NCC(C1=CC=CC=C1)C1=CC=CC=C1.NCC(=O)O Chemical compound C(=O)(O)C1(CC1)NCC(C1=CC=CC=C1)C1=CC=CC=C1.NCC(=O)O HDBSOQAIYPWDKZ-UHFFFAOYSA-N 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
229940123150 Chelating agent Drugs 0.000 description 1
102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 description 1
108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
108010069514 Cyclic Peptides Proteins 0.000 description 1
102000001189 Cyclic Peptides Human genes 0.000 description 1
XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 description 1
AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 description 1
AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 description 1
ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 1
MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
229930195711 D-Serine Natural products 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
229930028154 D-arginine Natural products 0.000 description 1
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
229930182847 D-glutamic acid Natural products 0.000 description 1
ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 1
229930195715 D-glutamine Natural products 0.000 description 1
HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 1
229930195721 D-histidine Natural products 0.000 description 1
229930182845 D-isoleucine Natural products 0.000 description 1
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 1
229930182819 D-leucine Natural products 0.000 description 1
KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 1
229930182818 D-methionine Natural products 0.000 description 1
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
229930182832 D-phenylalanine Natural products 0.000 description 1
229930182820 D-proline Natural products 0.000 description 1
AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 description 1
229930182822 D-threonine Natural products 0.000 description 1
229930182827 D-tryptophan Natural products 0.000 description 1
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 1
229930195709 D-tyrosine Natural products 0.000 description 1
KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 description 1
229930182831 D-valine Natural products 0.000 description 1
108091027757 Deoxyribozyme Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
241001269524 Dura Species 0.000 description 1
229930195710 D‐cysteine Natural products 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
108010055196 EphA2 Receptor Proteins 0.000 description 1
108010055191 EphA3 Receptor Proteins 0.000 description 1
108010055182 EphA5 Receptor Proteins 0.000 description 1
108010055207 EphA6 Receptor Proteins 0.000 description 1
108010055153 EphA7 Receptor Proteins 0.000 description 1
108010055155 EphA8 Receptor Proteins 0.000 description 1
108010055334 EphB2 Receptor Proteins 0.000 description 1
102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 1
102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 1
102100021605 Ephrin type-A receptor 5 Human genes 0.000 description 1
102100021606 Ephrin type-A receptor 7 Human genes 0.000 description 1
102100021601 Ephrin type-A receptor 8 Human genes 0.000 description 1
102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 1
102100031982 Ephrin type-B receptor 3 Human genes 0.000 description 1
102100031983 Ephrin type-B receptor 4 Human genes 0.000 description 1
102100031984 Ephrin type-B receptor 6 Human genes 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
229940127461 Growth Hormone Receptor Agonists Drugs 0.000 description 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
101001064458 Homo sapiens Ephrin type-B receptor 3 Proteins 0.000 description 1
101001064451 Homo sapiens Ephrin type-B receptor 6 Proteins 0.000 description 1
101000946053 Homo sapiens Lysosomal-associated transmembrane protein 4A Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
206010020880 Hypertrophy Diseases 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
GDFAOVXKHJXLEI-UHFFFAOYSA-N L-N-Boc-N-methylalanine Natural products CNC(C)C(O)=O GDFAOVXKHJXLEI-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
QWCKQJZIFLGMSD-VKHMYHEASA-N L-alpha-aminobutyric acid Chemical compound CC[C@H](N)C(O)=O QWCKQJZIFLGMSD-VKHMYHEASA-N 0.000 description 1
ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102100034728 Lysosomal-associated transmembrane protein 4A Human genes 0.000 description 1
238000000134 MTT assay Methods 0.000 description 1
231100000002 MTT assay Toxicity 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
108010013731 Myelin-Associated Glycoprotein Proteins 0.000 description 1
CZCIKBSVHDNIDH-NSHDSACASA-N N(alpha)-methyl-L-tryptophan Chemical compound C1=CC=C2C(C[C@H]([NH2+]C)C([O-])=O)=CNC2=C1 CZCIKBSVHDNIDH-NSHDSACASA-N 0.000 description 1
WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical compound OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
VKZGJEWGVNFKPE-UHFFFAOYSA-N N-Isobutylglycine Chemical compound CC(C)CNCC(O)=O VKZGJEWGVNFKPE-UHFFFAOYSA-N 0.000 description 1
SCIFESDRCALIIM-UHFFFAOYSA-N N-Me-Phenylalanine Natural products CNC(C(O)=O)CC1=CC=CC=C1 SCIFESDRCALIIM-UHFFFAOYSA-N 0.000 description 1
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
NTWVQPHTOUKMDI-YFKPBYRVSA-N N-Methyl-arginine Chemical compound CN[C@H](C(O)=O)CCCN=C(N)N NTWVQPHTOUKMDI-YFKPBYRVSA-N 0.000 description 1
GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
XLBVNMSMFQMKEY-BYPYZUCNSA-N N-methyl-L-glutamic acid Chemical compound CN[C@H](C(O)=O)CCC(O)=O XLBVNMSMFQMKEY-BYPYZUCNSA-N 0.000 description 1
YAXAFCHJCYILRU-YFKPBYRVSA-N N-methyl-L-methionine Chemical compound C[NH2+][C@H](C([O-])=O)CCSC YAXAFCHJCYILRU-YFKPBYRVSA-N 0.000 description 1
SCIFESDRCALIIM-VIFPVBQESA-N N-methyl-L-phenylalanine Chemical compound C[NH2+][C@H](C([O-])=O)CC1=CC=CC=C1 SCIFESDRCALIIM-VIFPVBQESA-N 0.000 description 1
AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical compound CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 description 1
CWLQUGTUXBXTLF-YFKPBYRVSA-N N-methylproline Chemical compound CN1CCC[C@H]1C(O)=O CWLQUGTUXBXTLF-YFKPBYRVSA-N 0.000 description 1
101150054880 NASP gene Proteins 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
102000010410 Nogo Proteins Human genes 0.000 description 1
108010077641 Nogo Proteins Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
150000007930 O-acyl isoureas Chemical class 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920006080 Polyloy® Polymers 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
102100035124 Rhotekin Human genes 0.000 description 1
101710122991 Rhotekin Proteins 0.000 description 1
108010057163 Ribonuclease III Proteins 0.000 description 1
102000003661 Ribonuclease III Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
101710184528 Scaffolding protein Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
NYTOUQBROMCLBJ-UHFFFAOYSA-N Tetranitromethane Chemical compound [O-][N+](=O)C([N+]([O-])=O)([N+]([O-])=O)[N+]([O-])=O NYTOUQBROMCLBJ-UHFFFAOYSA-N 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
238000012867 alanine scanning Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000005600 alkyl phosphonate group Chemical group 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
DLAMVQGYEVKIRE-UHFFFAOYSA-N alpha-(methylamino)isobutyric acid Chemical compound CNC(C)(C)C(O)=O DLAMVQGYEVKIRE-UHFFFAOYSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
229940093740 amino acid and derivative Drugs 0.000 description 1
229940067621 aminobutyrate Drugs 0.000 description 1
229960002684 aminocaproic acid Drugs 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
102000025171 antigen binding proteins Human genes 0.000 description 1
108091000831 antigen binding proteins Proteins 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000007321 biological mechanism Effects 0.000 description 1
230000008512 biological response Effects 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
230000008499 blood brain barrier function Effects 0.000 description 1
210000001218 blood-brain barrier Anatomy 0.000 description 1
125000001369 canonical nucleoside group Chemical group 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
210000003164 cauda equina Anatomy 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
AWGTVRDHKJQFAX-UHFFFAOYSA-M chloro(phenyl)mercury Chemical compound Cl[Hg]C1=CC=CC=C1 AWGTVRDHKJQFAX-UHFFFAOYSA-M 0.000 description 1
VIMWCINSBRXAQH-UHFFFAOYSA-M chloro-(2-hydroxy-5-nitrophenyl)mercury Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[Hg]Cl VIMWCINSBRXAQH-UHFFFAOYSA-M 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
230000019113 chromatin silencing Effects 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000024391 collateral sprouting Effects 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
238000010205 computational analysis Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
239000007859 condensation product Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000000942 confocal micrograph Methods 0.000 description 1
238000004624 confocal microscopy Methods 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
230000002594 corticospinal effect Effects 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
238000000326 densiometry Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
235000019441 ethanol Nutrition 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000834 fixative Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
229960003692 gamma aminobutyric acid Drugs 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000009688 glial response Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
229940015043 glyoxal Drugs 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
210000004884 grey matter Anatomy 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
239000004030 hiv protease inhibitor Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
150000002463 imidates Chemical class 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
230000030214 innervation Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
229960003299 ketamine Drugs 0.000 description 1
238000009533 lab test Methods 0.000 description 1
239000010410 layer Substances 0.000 description 1
150000002611 lead compounds Chemical class 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
239000013554 lipid monolayer Substances 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000005230 lumbar spinal cord Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
SJFKGZZCMREBQH-UHFFFAOYSA-N methyl ethanimidate Chemical compound COC(C)=N SJFKGZZCMREBQH-UHFFFAOYSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000000693 micelle Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
239000003595 mist Substances 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
210000000337 motor cortex Anatomy 0.000 description 1
210000002161 motor neuron Anatomy 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
XJODGRWDFZVTKW-ZCFIWIBFSA-N n-methylleucine Chemical compound CN[C@@H](C(O)=O)CC(C)C XJODGRWDFZVTKW-ZCFIWIBFSA-N 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
238000006396 nitration reaction Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
238000010422 painting Methods 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
229960001639 penicillamine Drugs 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
239000008196 pharmacological composition Substances 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
150000008298 phosphoramidates Chemical class 0.000 description 1
108091005981 phosphorylated proteins Proteins 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
229960001327 pyridoxal phosphate Drugs 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
229940044551 receptor antagonist Drugs 0.000 description 1
239000002464 receptor antagonist Substances 0.000 description 1
238000005932 reductive alkylation reaction Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
239000010979 ruby Substances 0.000 description 1
229910001750 ruby Inorganic materials 0.000 description 1
229940043230 sarcosine Drugs 0.000 description 1
210000004116 schwann cell Anatomy 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
230000007781 signaling event Effects 0.000 description 1
102000030938 small GTPase Human genes 0.000 description 1
108060007624 small GTPase Proteins 0.000 description 1
108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000012306 spectroscopic technique Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
229940014800 succinic anhydride Drugs 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
229940126577 synthetic vaccine Drugs 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
210000001364 upper extremity Anatomy 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
210000004885 white matter Anatomy 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
229960001600 xylazine Drugs 0.000 description 1